AAPL353.52+1.61 (+0.46%) ▲|ABBV288.51-4.31 (-1.47%) ▼|ABT104.38-0.33 (-0.32%) ▼|ACN232.36-6.93 (-2.89%) ▼|ADBE225.78-9.77 (-4.15%) ▼|AMAT347.16-2.07 (-0.59%) ▼|AMD507.16+3.75 (+0.74%) ▲|AMGN446.85-11.08 (-2.42%) ▼|AMT180.95-2.24 (-1.22%) ▼|AMZN264.25+6.36 (+2.46%) ▲|AVGO351.58+9.98 (+2.92%) ▲|AXP314.75-1.04 (-0.33%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.35-0.14 (-0.13%) ▼|SCHW92.39+0.56 (+0.61%) ▲|SO93.42-0.19 (-0.20%) ▼|SPG228.84-1.36 (-0.59%) ▼|T21.96-0.36 (-1.59%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN294.78-1.08 (-0.37%) ▼|UBER68.40-0.42 (-0.60%) ▼|UNH383.63-6.13 (-1.57%) ▼|UNP297.25+0.14 (+0.05%) ▲|UPS109.55-0.77 (-0.70%) ▼|USB59.04-0.15 (-0.26%) ▼|V416.45-0.53 (-0.13%) ▼|VZ45.43-0.51 (-1.11%) ▼|WFC82.21-0.50 (-0.60%) ▼|WMT126.22-1.30 (-1.02%) ▼|XOM165.50-1.72 (-1.03%) ▼|AAPL353.52+1.61 (+0.46%) ▲|ABBV288.51-4.31 (-1.47%) ▼|ABT104.38-0.33 (-0.32%) ▼|ACN232.36-6.93 (-2.89%) ▼|ADBE225.78-9.77 (-4.15%) ▼|AMAT347.16-2.07 (-0.59%) ▼|AMD507.16+3.75 (+0.74%) ▲|AMGN446.85-11.08 (-2.42%) ▼|AMT180.95-2.24 (-1.22%) ▼|AMZN264.25+6.36 (+2.46%) ▲|AVGO351.58+9.98 (+2.92%) ▲|AXP314.75-1.04 (-0.33%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.35-0.14 (-0.13%) ▼|SCHW92.39+0.56 (+0.61%) ▲|SO93.42-0.19 (-0.20%) ▼|SPG228.84-1.36 (-0.59%) ▼|T21.96-0.36 (-1.59%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN294.78-1.08 (-0.37%) ▼|UBER68.40-0.42 (-0.60%) ▼|UNH383.63-6.13 (-1.57%) ▼|UNP297.25+0.14 (+0.05%) ▲|UPS109.55-0.77 (-0.70%) ▼|USB59.04-0.15 (-0.26%) ▼|V416.45-0.53 (-0.13%) ▼|VZ45.43-0.51 (-1.11%) ▼|WFC82.21-0.50 (-0.60%) ▼|WMT126.22-1.30 (-1.02%) ▼|XOM165.50-1.72 (-1.03%) ▼|
13.3 C
New York
Wednesday, November 18, 2026

Press Releases

Insurance Agent Laura Wood Compares Term & Whole Life Insurance Benefits

Laura Wood explains how coverage duration, costs, and policy features affect life insurance decisions.KEY HIGHLIGHTSTerm life insurance provides coverage for a set period, often at a lower initial cost...

PI Holdings and Wallstreet Sand Co. Name Blaine Wilbanks President

Frac and pressure pumping veteran takes the lead at the high-volume Permian sand supplierFORT...

illumine Expands Multi-Site Management Capabilities to Help Childcare Groups Reduce Operational Risk and Scale with Confidence

WILMINGTON, Del., Nov. 18, 2026 /PRNewswire/ -- As childcare groups and Montessori school networks expand across...

Experts Warn of Lingering Pest-Borne Health Risks This Fall and Winter

The National Pest Management Association identifies top U.S. cities, along with additional hot spots,...

Century Communities to Host November Grand Opening for Six Model Homes at Two New Florence, AZ Communities

New homes in Florence, AZ are priced from the low $300s—with quick move-in, under-construction,...

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

Responses were deep and durable, with 65% ongoing at clinical cutoffResults support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase...

LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

A new, modern DORS and Field Clarity, the First AI-Guided Smartphone Video Assistant, Enhances Community Experience and Helps Improve Evidence, Case BuildingORLANDO, Fla., Oct....

Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration

Celebrities, athletes and creators came together for an action-packed night of gaming, immersive entertainment and exclusive experiences on Cosm's massive Shared Reality Display. INGLEWOOD, Calif.,...

From loss to lasting impact: More than $4.5M raised by the Orchid Women’s Health Initiative to change women’s health care in Nova Scotia

HALIFAX, NS, Oct. 25, 2026 /CNW/ -- What began as a tribute to a beloved friend has grown into a multimillion-dollar movement transforming women's...

Come Back to Firefox: Mozilla launches its most ambitious campaign yet to bring people back to the independent alternative to big tech browsers

As tracking and unwanted AI reshape the web, Firefox reunites the internet's original viral icons to make the case for a browser that puts...

COP17 welcomes Value Nature Fund’s approach to mobilizing private capital for nature

Fondaction and Triodos Bank demonstrate at COP17 how innovative finance can accelerate the implementation of global biodiversity goalsMONTREAL, Oct. 25, 2026 /CNW/ -- At...

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of...

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of...

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England...

PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P<0.0001...

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England...

PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P<0.0001...

Borr Drilling Limited – Prospector 5 Rig Incident

HAMILTON, Bermuda, October 25, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE and OSE: BORR) ("Borr Drilling") confirms that an incident occurred at approximately 20:37 local...

Best Protective iPhone Cases for 2026: Top Slim and Drop-Protection Options for iPhone 18 Pro & iPhone 18 Pro Max Recommended by Consumer365

NEW YORK, Oct. 25, 2026 /PRNewswire/ -- Consumer365 has recognized TORRAS in its review of the best iPhone cases for 2026, highlighting the Ostand Q3...

Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

JNJ-6143 is an investigational, once-daily, novel, small molecule designed to trigger cancer cell death through a targeted dual-protein lock between BRD4 and androgen receptor,...

New data on Lilly’s investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

Data presented at ESMO highlight the promising efficacy of olomorasib in combination with standard-of-care immunotherapy with or without chemotherapy in first-line advanced KRAS G12C-mutant...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomePress Releases